In conclusion, based on in vitro experiment results and the results from the online database analysis, we believe that FN1 could be used as a marker of ovarian cancer detection and could also be used as a progress indicator for ovarian cancer patients. This evidence concerns the gene FN1 and ovarian carcinoma.